| 價格 | 詢價 |
| 包裝 | 1removed |
| 最小起訂量 | 1removed |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-06-29 |
| 中文名稱:化合物 δ-secretase inhibitor 11 | 英文名稱:δ-secretase inhibitor 11 |
| CAS:842964-18-5 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 純度規(guī)格: 99.84% | 產(chǎn)品類別: 抑制劑 |
| 貨號: T001|T9713 |
| 名稱 | δ-secretase inhibitor 11 |
| 描述 | δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment. |
| 體外活性 | The inhibitory effect of δ-secretase inhibitor 11 on AEP activity in vitro was tested and the dose-response relationship revealed that the δ-secretase inhibitor 11 had an IC50 value of 0.15?±?0.09?μM [1]. |
| 體內(nèi)活性 | It was found that oral administration of δ-secretase inhibitor 11 (10?mg/kg) significantly suppressed brain AEP activity compared to the vehicle treatment. The concentrations of Aβ1–40 and Aβ1–42 in brain lysates of SAMP8 mice were significantly reduced due to AEP inhibition by δ-secretase inhibitor 11. [1] |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | DMSO : 2.21 mg/mL (10.03 mM), Sonication is recommended. |
| 關(guān)鍵字 | δ-Secretase inhibitor 11 | δsecretase inhibitor 11 | δ secretase inhibitor 11 | β-amyloid peptide | βAmyloid | β Amyloid | Pala cells | oxygen-glucose deprivation | Inhibitor | inhibit | delta-secretase inhibitor 11 | CNS diseases | Caspase | BetaAmyloid | Beta Amyloid | bAmyloid | b Amyloid | asparagine endopeptidase | APP | amyloid-β | amyloid precursor protein | Alzheimer's disease | AEP | Abeta |
| 相關(guān)產(chǎn)品 | Rutin | Magnesium acetate tetrahydrate | 2,4-Di-tert-butylphenol | Methyl tridecanoate | Benzenesulfonamide | 10-Undecenoic acid | HEPPS | Tauroursodeoxycholate | Chlorzoxazone | Phytic acid sodium salt | Cystamine dihydrochloride | Copper Sulfate Pentahydrate |
| 相關(guān)庫 | 抑制劑庫 | 細(xì)胞焦亡化合物庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 抗阿爾茨海默癥化合物庫 | 神經(jīng)信號分子庫 | 蛋白酶抑制劑庫 | 多靶點化合物庫 | 膜蛋白靶向化合物庫 |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP5年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2026-07-21 | |
| 詢價 |
VIP13年
|
深圳振強(qiáng)生物技術(shù)有限公司
|
2026-07-24 | |
| 詢價 |
VIP1年
|
陜西締都醫(yī)藥有限責(zé)任公司
|
2026-07-24 |